- Home
- VLY vs ZLAB Comparison
VLY vs ZLAB Comparison
Compare VLY & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLY
- ZLAB
- Stock Information
- Founded
- VLY 1927
- ZLAB 2013
- Country
- VLY United States
- ZLAB China
- Employees
- VLY N/A
- ZLAB N/A
- Industry
- VLY Major Banks
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- VLY Finance
- ZLAB Health Care
- Exchange
- VLY Nasdaq
- ZLAB Nasdaq
- Market Cap
- VLY 5.2B
- ZLAB 4.3B
- IPO Year
- VLY N/A
- ZLAB 2017
- Fundamental
- Price
- VLY $9.40
- ZLAB $34.96
- Analyst Decision
- VLY Buy
- ZLAB Buy
- Analyst Count
- VLY 11
- ZLAB 5
- Target Price
- VLY $11.05
- ZLAB $54.28
- AVG Volume (30 Days)
- VLY 7.5M
- ZLAB 860.8K
- Earning Date
- VLY 07-24-2025
- ZLAB 08-07-2025
- Dividend Yield
- VLY 4.68%
- ZLAB N/A
- EPS Growth
- VLY 9.83
- ZLAB N/A
- EPS
- VLY 0.78
- ZLAB N/A
- Revenue
- VLY $1,603,358,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- VLY $33.98
- ZLAB $45.16
- Revenue Next Year
- VLY $9.14
- ZLAB $56.81
- P/E Ratio
- VLY $12.05
- ZLAB N/A
- Revenue Growth
- VLY N/A
- ZLAB 32.56
- 52 Week Low
- VLY $7.48
- ZLAB $16.01
- 52 Week High
- VLY $11.10
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- VLY 52.83
- ZLAB 45.24
- Support Level
- VLY $9.08
- ZLAB $33.17
- Resistance Level
- VLY $9.39
- ZLAB $39.64
- Average True Range (ATR)
- VLY 0.22
- ZLAB 1.19
- MACD
- VLY -0.04
- ZLAB -0.31
- Stochastic Oscillator
- VLY 57.69
- ZLAB 22.29
About VLY Valley National Bancorp
Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.